SEC 13F Intelligence

Dekabank Deutsche Girozentrale / REGN

Dekabank Deutsche Girozentrale’s Regeneron Pharmaceuticals Position

Does Dekabank Deutsche Girozentrale own Regeneron Pharmaceuticals (REGN)? Yes — 211.2K shares worth $161M (+0.27% of its 13F portfolio) as of Q1 2026.

Position Value
$161M
Q1 2026
Shares
211.2K
% of Portfolio
+0.27%
Quarters Held
29
currently held

Position History REGN

Reported value by quarter
Q4 ’18: $14MQ4 ’18Q1 ’19: $19MQ2 ’19: $19MQ3 ’19: $13MQ4 ’19: $4MQ4 ’19Q1 ’20: $6MQ2 ’20: $8MQ3 ’20: $29MQ1 ’21: $37MQ1 ’21Q2 ’21: $46MQ3 ’21: $59MQ4 ’21: $68MQ1 ’22: $106MQ1 ’22Q2 ’22: $102MQ3 ’22: $123MQ4 ’22: $122MQ1 ’23: $140MQ1 ’23Q2 ’23: $119MQ3 ’23: $167MQ4 ’23: $196MQ1 ’24: $213MQ1 ’24Q2 ’24: $224MQ3 ’24: $219MQ4 ’24: $148MQ1 ’25: $139MQ1 ’25Q2 ’25: $110MQ3 ’25: $118MQ4 ’25: $207MQ1 ’26: $161MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026211.2K$161M+0.27%
Q4 2025211.2K$207M+0.36%
Q3 2025211.2K$118M+0.20%
Q2 2025211.2K$110M+0.20%
Q1 2025221.2K$139M+0.27%
Q4 2024211.2K$148M+0.27%
Q3 2024211.2K$219M+0.41%
Q2 2024213.8K$224M+0.40%
Q1 2024221.2K$213M+0.40%
Q4 2023224.2K$196M+0.40%
Q3 2023200.4K$167M+0.38%
Q2 2023167.9K$119M+0.27%
Q1 2023173.7K$140M+0.35%
Q4 2022171.0K$122M+0.32%
Q3 2022178.9K$123M+0.36%
Q2 2022171.2K$102M+0.30%
Q1 2022151.0K$106M+0.26%
Q4 2021105.5K$68M+0.17%
Q3 202196.5K$59M+0.17%
Q2 202183.7K$46M+0.13%
Q1 202178.9K$37M+0.12%
Q3 202049.4K$29M+0.13%
Q2 202013.1K$8M+0.05%
Q1 202011.5K$6M+0.04%
Q4 201911.5K$4M+0.03%
Q3 201949.0K$13M+0.08%
Q2 201959.7K$19M+0.09%
Q1 201947.2K$19M+0.12%
Q4 201839.0K$14M+0.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dekabank Deutsche Girozentrale’s full portfolio or all institutional holders of REGN.